Bryan Kee

4PUBLICATIONS
79CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 16, 2025
Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT.

Andrew J Pellatt, Alisha Bent, Nicholas Hornstein

|Dec 16, 2024
The Landscape of ctDNA in Appendiceal Adenocarcinoma.

Michael G White, Mohammad A Zeineddine, Eleanor A Fallon

|Dec 12, 2023
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination.

Kristen Simmons, Jane V Thomas, Kaysia Ludford

|May 12, 2023
Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer.

Apostolia M Tsimberidou, Kerstin Guenther, Borje S Andersson

Pageof 1

Frequent Collaborators

3 joint publications

Kanwal Raghav

3 joint publications

Michael Overman

3 joint publications

Arvind Dasari

3 joint publications

Scott Kopetz